86 related articles for article (PubMed ID: 7335366)
21. Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study.
Recchia F; Rea S; Pompili P; Casucci D; Rea MJ; Rizzo F; Gulino A; Frati L
Clin Ter; 1995 Oct; 146(10):603-10. PubMed ID: 8585877
[TBL] [Abstract][Full Text] [Related]
22. [Combination drug-hormone therapy of the advanced stages of breast carcinoma].
Fazio M; Cavallero P; Rattalino G; Sartoris S; Vergnano F
Minerva Ginecol; 1976; 28(7-8):623-9. PubMed ID: 1037112
[No Abstract] [Full Text] [Related]
23. [Hormone-drug therapy combination in the treatment of breast cancer].
Pérez Manga G; Madrigal Alonso PL; Pérez Gómez FJ
Acta Oncol (Madr); 1975 Dec; 10(3):153-68. PubMed ID: 1211117
[No Abstract] [Full Text] [Related]
24. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of implantable injection port for advanced breast cancer patients].
Nakamura S; Itoh M; Ohigashi S; Nishio T; Abe O; Sakurai K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1529-32. PubMed ID: 8854798
[TBL] [Abstract][Full Text] [Related]
26. [Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
Mitsuyama S; Kuroda Y; Ohsato K; Nakamura Y; Murakami F; Nishikata F; Ikeda S; Egami T; Mori A; Ohe H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1153-60. PubMed ID: 8751803
[TBL] [Abstract][Full Text] [Related]
27. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
[No Abstract] [Full Text] [Related]
28. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
Friedman MA; Marcus F; Kohler M; Resser KJ
Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
[No Abstract] [Full Text] [Related]
29. L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: a pilot study.
Tormey DC; Bull JM; Lipman ML
Cancer Treat Rep; 1980; 64(8-9):1015-6. PubMed ID: 7448819
[No Abstract] [Full Text] [Related]
30. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy and tamoxifen for breast cancer.
N Engl J Med; 1981 Oct; 305(17):1014-5. PubMed ID: 7278914
[No Abstract] [Full Text] [Related]
32. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
[TBL] [Abstract][Full Text] [Related]
33. Pilot study of formestane in postmenopausal women with breast cancer.
Joseph JK; Lim AK
Med J Malaysia; 1998 Mar; 53(1):37-41. PubMed ID: 10968135
[TBL] [Abstract][Full Text] [Related]
34. Natural interferon-beta and tamoxifen in hormone-resistant patients with advanced breast cancer.
Buzzi E; Brugia M; Trippa F; Rossi G; Trivisonne R; Giustini L; Pinaglia D; Capparella V; Sica G
Anticancer Res; 1995; 15(5B):2187-90. PubMed ID: 8572622
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
36. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of CAF plus MPA with CAF plus TAM for advanced or recurrent breast cancer--Kyushu CAFT Study Group of Advanced or Recurrent Breast Cancer].
Mitsuyama S; Tashiro H; Koga T; Maehara Y; Ogawa M; Kakegawa T; Shimazu H; Sugimachi K; Tomita M; Nakamura Y
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2073-80. PubMed ID: 8607618
[TBL] [Abstract][Full Text] [Related]
38. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.
Harris EE; Christensen VJ; Hwang WT; Fox K; Solin LJ
J Clin Oncol; 2005 Jan; 23(1):11-6. PubMed ID: 15545665
[TBL] [Abstract][Full Text] [Related]
39. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
40. [Chemotherapy of carcinoma of the breast].
Periti P; Mazzei T
Minerva Ginecol; 1982 Nov; 34(11):959-62. PubMed ID: 7155423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
